Pharsight

Drugs that contain Azithromycin

1. List of Zmax drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6984403 PF PRISM CV Azithromycin dosage forms with reduced side effects
Feb, 2024

(1 year, 4 days from now)

US7887844 PF PRISM CV Multiparticulate crystalline drug compositions having controlled release profiles
Feb, 2024

(1 year, 4 days from now)

Market Authorisation Date: 10 June, 2005

Treatment: Method of treating bacterial infections

Dosage: FOR SUSPENSION, EXTENDED RELEASE;ORAL

More Information on Dosage

ZMAX family patents

7

United States

2

Poland

2

Japan

2

IB

1

Austria

1

Morocco

1

Hong Kong

1

Korea, Republic of

1

AP

1

Brazil

1

Australia

1

Chile

1

Ukraine

1

Guatemala

1

Dominican Republic

1

Yugoslavia

1

Uruguay

1

Netherlands

1

Spain

1

Germany

1

Israel

1

Cyprus

1

OA

1

Mexico

1

Tunisia

1

Slovenia

1

South Africa

1

Argentina

1

Portugal

1

Georgia

1

Peru

1

EA

1

China

1

Croatia

1

Panama

1

Norway

1

Iceland

1

Canada

1

New Zealand

1

Taiwan, Province of China

1

Denmark

1

Costa Rica

1

Ecuador

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic